Concepedia

Lu Xu

LX

5

Publications

337

Citations

5

H-Index

2017

Active since

Affiliations

Beijing Anzhen Hospital(Current)

Capital Medical University

Beijing Tian Tan Hospital

Hainan Medical College Hospital

First Affiliated Hospital of Dalian Medical University

Lu Xu is an author at Beijing Anzhen Hospital specializing in tumor immunology, radiation oncology, and immunology.

ORCID

Top concepts

Publications per year

2017–2019

5

Publications

5

Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects

Lu Xu, Yang Zhang, Kang Tian et al. · Journal of Experimental & Clinical Cancer Research · 2018 · 169 citations · Full text

Phase I/II clinical trial of a Wilms’ tumor 1-targeted dendritic cell vaccination-based immunotherapy in patients with advanced cancer

Wen Zhang, Lu Xu, Peilin Cui et al. · Cancer Immunology Immunotherapy · 2018 · 72 citations · Full text

, , +10

Prostaglandin E2 and PD-1 mediated inhibition of antitumor CTL responses in the human tumor microenvironment

Jie Miao, Lu Xu, Yuefeng Hu et al. · Oncotarget · 2017 · 59 citations · Full text

The exon 19-deleted EGFR undergoes ubiquitylation-mediated endocytic degradation via dynamin activity-dependent and -independent mechanisms

Taishu Wang, Jinrui Zhang, Shanshan Wang et al. · Cell Communication and Signaling · 2018 · 23 citations · Full text

Synergistic effect of adoptive immunotherapy and docetaxel inhibits tumor growth in a mouse model

Yuefeng Hu, Jingwei Liu, Peilin Cui et al. · Cellular Immunology · 2019 · 14 citations · Full text

, , +10

Rows per page

1–5 of 5